Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

2 passages

referencesuptodate· REFERENCES· item f14_49_15127

REFERENCES Chung CH, Mirakhur B, Chan E, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 2008; 358:1109. Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011; 127:S1. King TP, Hoffman D, Løwenstein H, Marsh DG, Platts-Mills TAE, Thomas W. Allergen Nomenclature, J Allergy Clin Immunol 1995; 96:5. Løwenstein H. Selection of reference preparation. IUIS reference preparation criteria. Arb Paul Ehrlich Inst 1987; 80:75. Løwenstein H, Marsh DG. Antigens of Ambrosia elatior (short ragweed) pollen. I. Crossed immunoelectrophoretic analyses. J Immunol 1981; 126:943. Marsh DG, Norman PS, Roebber M, Lichtenstein LM. Studies on allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps. J Allergy Clin Immunol 1981; 68:449. Lüderitz-Püchel U, Keller-Stanislawski B, Haustein D. Neubewertung des Risikos von Test- und Therapieallergenen. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 2001; 44:709. Norman PS, Ohman JL Jr, Long AA, et al. Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 1996; 154:1623. Butler NR, Voyce MA, Burland WL, Hilton ML. Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus, and pertussis vaccines for the immunization of infants. Br Med J 1969; 1:663. Mellerup MT, Hahn GW, Poulsen LK, Malling H. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy 2000; 30:1423. Marrack P, McKee AS, Munks MW. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 2009; 9:287. al-Shakhshir RH, Regnier FE, White JL, Hem SL. Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants. Vaccine 1995; 13:41. Akdis CA, Blaser K. Regulation of specific immune responses by chemical and structural modifications of allergens. Int Arch Allergy Immunol 2000; 121:261. Ferreira F, Briza P, Inführ D, et al. Modified recombinant allergens for safer immunotherapy. Inflamm Allergy Drug Targets 2006; 5:5. Larsen JN, Houghton CG, Vega ML, Løwenstein H. Manufacturing and standardizing allergen extracts in Europe. Clin Allergy Immunol 2008; 21:283.

referencesuptodate· REFERENCES· item f14_49_15127

Akdis CA, Blaser K. Regulation of specific immune responses by chemical and structural modifications of allergens. Int Arch Allergy Immunol 2000; 121:261. Ferreira F, Briza P, Inführ D, et al. Modified recombinant allergens for safer immunotherapy. Inflamm Allergy Drug Targets 2006; 5:5. Larsen JN, Houghton CG, Vega ML, Løwenstein H. Manufacturing and standardizing allergen extracts in Europe. Clin Allergy Immunol 2008; 21:283. Slater JE. Standardized allergen vaccines in the United States. Clin Allergy Immunol 2008; 21:273. Løwenstein H. Physico chemical and immunochemical methods for the control of potency and quality of allergenic extracts. Arb Paul Ehrlich Inst 1980; 75:122. Council of Europe. European Pharmacopoeia. European Treaty Series 50, Strasbourg, France, 2001. Kaul S, May S, Lüttkopf D, Vieths S. Regulatory environment for allergen-specific immunotherapy. Allergy 2011; 66:753. van Ree R, Chapman MD, Ferreira F, et al. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy 2008; 63:310. Seppälä U, Dauly C, Robinson S, et al. Absolute quantification of allergens from complex mixtures: a new sensitive tool for standardization of allergen extracts for specific immunotherapy. J Proteome Res 2011; 10:2113. Nordic Council on Medicines. Registration of Allergen preparations: Nordic Guidelines. NLN Publication No 23, 1989, p. 1. Turkeltaub PC. Biological standardization based on quantitative skin testing--the ID50 EAL method (intradermal dilution for 50 mm sum of erythema diameters determines the allergy unit). Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M 1987; :169. Topic 363 Version 4.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1104-202.43.93.2-481E12C6DB-S244013.14]